Boris Görg

Dr. Boris Görg


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
BGBoris Görg
Boris Görg
AKAyşe Karababa
Ayşe Karababa
ESElina Schütz
Elina Schütz
MPMartha Paluschinski
Martha Paluschinski
ASAlina Schrimpf
Alina Schrimpf
DHDieter Häussinger
Dieter Häussinger

12 January 2022 in Analytical Biochemistry
Verified
Journal Article
Closed access
ASAlina Schrimpf
Alina Schrimpf
OKOlivia Knappe
Olivia Knappe
NQNatalia Qvartskhava
Natalia Qvartskhava
GPGereon Poschmann
Gereon Poschmann
KSKai Stühler
Kai Stühler
BGBoris Görg
Boris Görg

30 September 2019 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
OSOlga A. Sergeeva
Olga A. Sergeeva
ACAisa N. Chepkova
Aisa N. Chepkova
BGBoris Görg
Boris Görg
FAFilipe Rodrigues Almeida
Filipe Rodrigues Almeida
HBHans‐Jürgen Bidmon
Hans‐Jürgen Bidmon
DHDieter Häussinger
Dieter Häussinger
Aims: Histamine H3 receptor (H3R) antagonists/inverse agonists increase vigilance. We studied brain histaminergic pathways under hyperammonemia and the transcriptome of receptors and their signaling cascades to provide a rationale for wake‐promoting therapies.Methods: We analyzed histamine‐induced long‐lasting depression of corticostriatal synaptic transmission (LLDhist). As the expression of dopamine 1 receptors (D1R) is upregulated in LGS‐KO striatum where D1R‐H3R dimers may exist, we investigated actions of H3R and D1R agonists and antagonists. We analyzed transcription of selected genes in cortex and dorsal striatum in a mouse model of inborn hyperammonemia (liver‐specific glutamine synthetase knockout: LGS‐KO) and compared it with human hepatic encephalopathy.Results: LGS‐KO mice showed significant reduction of the direct depression (DD) but not the long‐lasting depression (LLD) by histamine. Neither pharmacological activation nor inhibition of D1R significantly affected DDhist and LLDhist in WT striatum, while in LGS‐KO mice D1R activation suppressed LLDhist. Histaminergic signaling was found unchanged at the transcriptional level except for the H2R. A study of cAMP‐regulated genes indicated a significant reduction in the molecular signature of wakefulness in the diseased cortex.Conclusions: Our findings provide a rationale for the development of aminergic wake‐promoting therapeutics in hyperammonemic disorders.

1 February 2017 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
PDF file
AKAyşe Karababa
Ayşe Karababa
BGBoris Görg
Boris Görg
ESElina Schütz
Elina Schütz
HBHans J. Bidmon
Hans J. Bidmon
DHDieter Häussinger
Dieter Häussinger